Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

1.

Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease.

Maliken BD, Nelson JE, Klintworth HM, Beauchamp M, Yeh MM, Kowdley KV.

Hepatology. 2013 May;57(5):1806-13. doi: 10.1002/hep.26238. Epub 2013 Mar 14.

PMID:
23325576
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations.

Nelson JE, Brunt EM, Kowdley KV; Nonalcoholic Steatohepatitis Clinical Research Network.

Hepatology. 2012 Nov;56(5):1730-40. doi: 10.1002/hep.25856. Epub 2012 Sep 20.

PMID:
22611049
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease.

Nelson JE, Wilson L, Brunt EM, Yeh MM, Kleiner DE, Unalp-Arida A, Kowdley KV; Nonalcoholic Steatohepatitis Clinical Research Network.

Hepatology. 2011 Feb;53(2):448-57. doi: 10.1002/hep.24038. Epub 2010 Nov 29.

PMID:
21274866
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers.

Shen J, Chan HL, Wong GL, Chan AW, Choi PC, Chan HY, Chim AM, Yeung DK, Yu J, Chu WC, Wong VW.

Aliment Pharmacol Ther. 2012 Dec;36(11-12):1057-66. doi: 10.1111/apt.12091. Epub 2012 Oct 16.

PMID:
23066946
[PubMed - indexed for MEDLINE]
5.

Serum cytokeratin-18 fragment levels are useful biomarkers for nonalcoholic steatohepatitis in children.

Feldstein AE, Alkhouri N, De Vito R, Alisi A, Lopez R, Nobili V.

Am J Gastroenterol. 2013 Sep;108(9):1526-31. doi: 10.1038/ajg.2013.168. Epub 2013 Jun 11.

PMID:
23752877
[PubMed - indexed for MEDLINE]
6.

Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis.

Yilmaz Y, Dolar E, Ulukaya E, Akgoz S, Keskin M, Kiyici M, Aker S, Yilmaztepe A, Gurel S, Gulten M, Nak SG.

World J Gastroenterol. 2007 Feb 14;13(6):837-44.

PMID:
17352011
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Elevated serum levels of cell death circulating biomarkers, M30 and M65, in patients with β-thalassemia major.

Esmaeil N, Moayedi B, Gharagozloo M, Maracy MR.

Hemoglobin. 2013;37(4):404-10. doi: 10.3109/03630269.2013.790828. Epub 2013 Apr 19.

PMID:
23600495
[PubMed - indexed for MEDLINE]
8.

Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease.

Kowdley KV, Belt P, Wilson LA, Yeh MM, Neuschwander-Tetri BA, Chalasani N, Sanyal AJ, Nelson JE; NASH Clinical Research Network.

Hepatology. 2012 Jan;55(1):77-85. doi: 10.1002/hep.24706. Epub 2011 Dec 6.

PMID:
21953442
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Serum fragmented cytokeratin 18 levels reflect the histologic activity score of nonalcoholic fatty liver disease more accurately than serum alanine aminotransferase levels.

Tsutsui M, Tanaka N, Kawakubo M, Sheena Y, Horiuchi A, Komatsu M, Nagaya T, Joshita S, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Aoyama T, Tanaka E, Sano K.

J Clin Gastroenterol. 2010 Jul;44(6):440-7. doi: 10.1097/MCG.0b013e3181bdefe2.

PMID:
20104187
[PubMed - indexed for MEDLINE]
10.

A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).

Younossi ZM, Jarrar M, Nugent C, Randhawa M, Afendy M, Stepanova M, Rafiq N, Goodman Z, Chandhoke V, Baranova A.

Obes Surg. 2008 Nov;18(11):1430-7. doi: 10.1007/s11695-008-9506-y. Epub 2008 May 24.

PMID:
18500507
[PubMed - indexed for MEDLINE]
11.

Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients.

Kahraman A, Sowa JP, Schlattjan M, Sydor S, Pronadl M, Wree A, Beilfuss A, Kilicarslan A, Altinbaş A, Bechmann LP, Syn WK, Gerken G, Canbay A.

Clin Sci (Lond). 2013 Oct;125(8):391-400. doi: 10.1042/CS20120542.

PMID:
23627434
[PubMed - indexed for MEDLINE]
12.

The oxidant/antioxidant status and cell death mode in oral squamous cell carcinoma.

Barut O, Vural P, Şirin Ş, Aydin S, Dizdar Y.

Acta Odontol Scand. 2012 Jul;70(4):303-8. doi: 10.3109/00016357.2011.600720. Epub 2011 Aug 5.

PMID:
21815836
[PubMed - indexed for MEDLINE]
13.

Major histocompatibility complex class I-related chains A and B (MIC A/B): a novel role in nonalcoholic steatohepatitis.

Kahraman A, Schlattjan M, Kocabayoglu P, Yildiz-Meziletoglu S, Schlensak M, Fingas CD, Wedemeyer I, Marquitan G, Gieseler RK, Baba HA, Gerken G, Canbay A.

Hepatology. 2010 Jan;51(1):92-102. doi: 10.1002/hep.23253.

PMID:
19998387
[PubMed - indexed for MEDLINE]
14.

Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis.

Joka D, Wahl K, Moeller S, Schlue J, Vaske B, Bahr MJ, Manns MP, Schulze-Osthoff K, Bantel H.

Hepatology. 2012 Feb;55(2):455-64. doi: 10.1002/hep.24734. Epub 2011 Nov 29.

PMID:
21993925
[PubMed - indexed for MEDLINE]
15.

Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index.

Polyzos SA, Kountouras J, Papatheodorou A, Katsiki E, Patsiaoura K, Zafeiriadou E, Papadopoulou E, Zavos C, Terpos E.

Ann Hepatol. 2013 Sep-Oct;12(5):749-57.

PMID:
24067262
[PubMed - indexed for MEDLINE]
16.

In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease.

Wieckowska A, Zein NN, Yerian LM, Lopez AR, McCullough AJ, Feldstein AE.

Hepatology. 2006 Jul;44(1):27-33.

PMID:
16799979
[PubMed - indexed for MEDLINE]
17.

Is alanine aminotransferase level a surrogate biomarker of hepatic apoptosis in nonalcoholic fatty liver disease?

Canbakan B, Senturk H, Canbakan M, Toptas T, Tabak O, Balci H, Olgac V, Ozbay G.

Biomark Med. 2010 Apr;4(2):205-14. doi: 10.2217/bmm.09.88.

PMID:
20406065
[PubMed - indexed for MEDLINE]
18.

Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease.

Sumida Y, Nakashima T, Yoh T, Furutani M, Hirohama A, Kakisaka Y, Nakajima Y, Ishikawa H, Mitsuyoshi H, Okanoue T, Kashima K, Nakamura H, Yodoi J.

J Hepatol. 2003 Jan;38(1):32-8.

PMID:
12480557
[PubMed - indexed for MEDLINE]
19.

Apoptotic and anti-apoptotic seromarkers for assessment of disease severity of non-alcoholic steatohepatitis.

El Bassat H, Ziada DH, Hasby EA, Nagy H, Abo Ryia MH.

Arab J Gastroenterol. 2014 Mar;15(1):6-11. doi: 10.1016/j.ajg.2014.01.009. Epub 2014 Feb 7.

PMID:
24630506
[PubMed - indexed for MEDLINE]
20.

[Association of hepatic iron deposition and serum iron indices with hepatic inflammation and fibrosis stage in nonalcoholic fatty liver disease].

Moon JH, Park SH, Oh KC, Jung JO, Shin WG, Kim JP, Kim KO, Park CH, Hahn T, Yoo KS, Kim JH, Kim DJ, Lee MS, Park CK, Jun SY.

Korean J Gastroenterol. 2006 Jun;47(6):432-9. Korean.

PMID:
16809950
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk